Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 242 are a BUY (84.32%), 37 are a HOLD (12.89%), 8 are a SELL (2.79%).
Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 53.89% that have a potential upside of 27.81% achieved within 197 days.
Mark Massaro’s has documented 559 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IDXX, IDEXX Laboratories at 05-Aug-2025.
Analyst best performing recommendations are on TKNO (ALPHA TEKNOVA).
The best stock recommendation documented was for GHDX (GENOMIC HEALTH) at 11/7/2018. The price target of $82 was fulfilled within 2 days with a profit of $8.18 (9.07%) receiving and performance score of 45.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$2.46 (19.62%)
$13
5 days ago
(06-Aug-2025)
9/14 (64.29%)
$3.31 (28.31%)
208
Hold
$9
$-3.54 (-28.23%)
$10
3 months 6 days ago
(05-May-2025)
3/7 (42.86%)
$-1.03 (-10.27%)
189
Buy
$10
$-2.54 (-20.26%)
$9
3 months 9 days ago
(02-May-2025)
5/6 (83.33%)
$0.16 (1.63%)
96
Buy
$9
$-3.54 (-28.23%)
$8
7 months 24 days ago
(18-Dec-2024)
5/8 (62.5%)
$3.03 (50.75%)
108
Buy
$6
$-6.54 (-52.15%)
$8
1 years 9 days ago
(02-Aug-2024)
2/2 (100%)
$1.7 (39.53%)
222
Which stock is Mark Massaro is most bullish on?
What Year was the first public recommendation made by Mark Massaro?